ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 20th, 2012 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California
This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of January 19, 2012 (the “Effective Date”) by and between Solana Therapeutics, Inc., a Delaware corporation (“Solana”), and La Jolla Pharmaceutical Company, a Delaware corporation (“La Jolla”). Solana and La Jolla may each be referred to herein individually as a “Party” and collectively as the “Parties.”
CONSENT AND AMENDMENT AGREEMENTConsent and Amendment Agreement • January 20th, 2012 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California
This CONSENT AND AMENDMENT AGREEMENT (this “Agreement”), entered into as of the 19th day of January, 2012 (the “Effective Date”), is made by and among La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”), and the undersigned parties (each a “Holder” and collectively the “Holders”).
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMSSeparation Agreement • January 20th, 2012 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California
This Confidential Separation Agreement and General Release of All Claims (“Separation Agreement”) is made by and between La Jolla Pharmaceutical Company (“Company”) and Gail A. Sloan (“Executive”) with respect to the following facts:
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMSConfidential Separation Agreement • January 20th, 2012 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California
This Confidential Separation Agreement and General Release of All Claims (“Separation Agreement”) is made by and between La Jolla Pharmaceutical Company (“Company”) and Deirdre Y. Gillespie, M.D. (“Executive”) with respect to the following facts:
